0000885590-12-000075.txt : 20121109 0000885590-12-000075.hdr.sgml : 20121109 20121109155326 ACCESSION NUMBER: 0000885590-12-000075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121108 FILED AS OF DATE: 20121109 DATE AS OF CHANGE: 20121109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DE SILVA RAJIV CENTRAL INDEX KEY: 0001453140 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 121193577 MAIL ADDRESS: STREET 1: 4787 LEVY STREET CITY: MONTREAL STATE: A8 ZIP: H4R 2P9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4787 LEVY STREET STREET 2: MONTREAL CITY: QUEBEC STATE: A8 ZIP: H4R 2P9 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 4787 LEVY STREET STREET 2: MONTREAL CITY: QUEBEC STATE: A8 ZIP: H4R 2P9 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2012-11-08 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001453140 DE SILVA RAJIV 4787 LEVY STREET MONTREAL A8 H4R 2P9 QUEBEC, CANADA 0 1 0 0 Pres & COO, Specialty Pharm Common Stock, no par value 2012-11-08 4 M 0 76344 25.42 A 341561 D Common Stock, no par value 2012-11-08 4 S 0 76344 54.0406 D 265217 D Non-Qualified Stock Options (right to purchase) 25.42 2012-11-08 4 M 0 76344 0 D 2012-10-08 2015-11-11 Common Stock, no par value 76344 96136 D This number represents the weighted average sale price for all sales of common stock sold by the reporting officer. The actual sale prices range from $54.00 to $54.34. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price. This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1. by: Nicholas Zanoni for Rajiv De Silva 2012-11-09